Skip to main content

Table 1 Characteristics of the patient cohort in the first stage of the study

From: A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients

Variables

POS*

 

NEG*

 

P

 

N

(%)

N

(%)

 

Number of patients

458

(41.49)

646

(58.51)

 

Age

70.8 ± 6.9

 

67.4 ± 8.4

 

<0.001

PSA

120.4 ± 15.0

 

13.7 ± 18.0

 

<0.001

PV

41.2 ± 24.4

 

48.2 ± 27.6

 

<0.001

PSAD

2.9 ± 13.5

 

0.3 ± 0.4

 

<0.001

f/t

0.12 ± 0.07

 

0.16 ± 0.10

 

<0.001

DRE findings

    

<0.001

neg*

234

(28.6)

585

(71.4)

 

pos*

224

(78.6)

61

(21.4)

 

Hypoechoic#

    

<0.001

neg*

307

(37.2)

518

(62.8)

 

pos*

151

(54.1)

128

(45.9)

 

Microcalcification#

    

0.592

neg*

319

(40.9)

460

(59.1)

 

pos*

139

(42.8)

186

(57.2)

 
  1. *neg, negative; *pos, positive.
  2. #Hypoechoic masses and microcalcifications were observed using ultrasound.